William Robert Moore - Publications

Affiliations: 
1972 Massachusetts Institute of Technology, Cambridge, MA, United States 
 1972-1997 West Virginia University, Morgantown, WV, United States 
Area:
physical organic chemistry
Website:
http://eberly.wvu.edu/eberly_news/2010/1/7/c--eugene-bennett-department-of-chemistry-holds-memorial-service-for-moore

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Garvey EP, Hoekstra WJ, Moore WR, Schotzinger RJ, Long L, Ghannoum MA. VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model. Antimicrobial Agents and Chemotherapy. 59: 1992-7. PMID 25605358 DOI: 10.1128/AAC.04902-14  0.64
2015 Steffen MW, Hazelton AC, Moore WR, Jenkins SM, Clark MM, Hagen PT. Improving sleep: outcomes from a worksite healthy sleep program. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 57: 1-5. PMID 25563534 DOI: 10.1097/JOM.0000000000000370  0.01
2014 Warrilow AG, Hull CM, Parker JE, Garvey EP, Hoekstra WJ, Moore WR, Schotzinger RJ, Kelly DE, Kelly SL. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrobial Agents and Chemotherapy. 58: 7121-7. PMID 25224009 DOI: 10.1128/AAC.03707-14  0.64
2014 Hoekstra WJ, Garvey EP, Moore WR, Rafferty SW, Yates CM, Schotzinger RJ. Design and optimization of highly-selective fungal CYP51 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 3455-8. PMID 24948565 DOI: 10.1016/j.bmcl.2014.05.068  0.64
2012 Gardner ER, Kelly M, Springman E, Lee KJ, Li H, Moore W, Figg WD. Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab. Investigational New Drugs. 30: 90-7. PMID 20820910 DOI: 10.1007/S10637-010-9520-5  0.64
2011 Shetty RS, Lee Y, Liu B, Husain A, Joseph RW, Lu Y, Nelson D, Mihelcic J, Chao W, Moffett KK, Schumacher A, Flubacher D, Stojanovic A, Bukhtiyarova M, Williams K, ... ... Moore WR, et al. Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent. Journal of Medicinal Chemistry. 54: 179-200. PMID 21126027 DOI: 10.1021/Jm100659V  0.64
2005 Krahn LE, Lymp JF, Moore WR, Slocumb N, Silber MH. Characterizing the emotions that trigger cataplexy. The Journal of Neuropsychiatry and Clinical Neurosciences. 17: 45-50. PMID 15746482 DOI: 10.1176/JNP.17.1.45  0.01
2003 Olson EJ, Moore WR, Morgenthaler TI, Gay PC, Staats BA. Obstructive sleep apnea-hypopnea syndrome. Mayo Clinic Proceedings. 78: 1545-52. PMID 14661684 DOI: 10.4065/78.12.1545  0.01
2003 Weintraub PM, Holland AK, Gates CA, Moore WR, Resvick RJ, Bey P, Peet NP. Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase. Bioorganic & Medicinal Chemistry. 11: 427-31. PMID 12517438 DOI: 10.1016/S0968-0896(02)00434-0  0.64
1999 Cregar L, Elrod KC, Putnam D, Moore WR. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase. Archives of Biochemistry and Biophysics. 366: 125-30. PMID 10334872 DOI: 10.1006/abbi.1999.1220  0.64
1998 Rice KD, Tanaka RD, Katz BA, Numerof RP, Moore WR. Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Current Pharmaceutical Design. 4: 381-96. PMID 10197050  0.64
1972 Moore WR, Bach RD. Bldg. Von Optisch Aktivem Cyclononadien-(1,2) Aus Zwei Verschiedenen Cyclopropyliden-Vorstufen Cheminform. 3. DOI: 10.1002/Chin.197229216  0.56
1971 Crabbé P, Velarde E, Anderson HW, Clark SD, Moore WR, Drake AF, Mason SF. Optical activity and absolute configuration of chiral allenes Journal of the Chemical Society D: Chemical Communications. 1261-1264. DOI: 10.1039/C29710001261  0.64
1970 Cope AC, Moore WR, Bach RD, Winkler HJS. Molecular asymmetry. IX. The partial resolution and asymmetric synthesis of 1,2-cyclononadiene Journal of the American Chemical Society. 92: 1243-1247. DOI: 10.1021/Ja00708A023  0.64
1970 Moore WR, Hill JB. Selective insertion in the formation of bicyclobutanes from tetraalkylsubstituted gem-dibromocyclopropanes Tetrahedron Letters. 11: 4343-4346. DOI: 10.1016/S0040-4039(00)89481-2  0.64
1970 Moore WR, Hill JB. Competitive bicyclobutane and allene formation from phenyl-substituted gem-dibromocyclopropanes Tetrahedron Letters. 11: 4553-4556. DOI: 10.1016/S0040-4039(00)89415-0  0.64
1970 Cope AC, Moore WR, Bach RD, Winkler HJS. Molekuelasymmetrie 9. Mitt. Teilspaltung Und Asymmetrische Synth. Von Cyclononadien-(1,2) Cheminform. 1. DOI: 10.1002/Chin.197022108  1
1969 Moore WR, Bach RD, Ozretich TM. Dimerization of racemic and optically active 1,2-cyclononadiene Journal of the American Chemical Society. 91: 5918-5919. DOI: 10.1021/Ja01049A059  0.56
1961 Cope AC, LeBel NA, Moore PT, Moore WR. Mechanism of the Hofmann elimination reaction: Evidence that an ylide intermediate is not involved in simple compounds Journal of the American Chemical Society. 83: 3861-3865. DOI: 10.1021/Ja01479A029  0.64
1960 Cope AC, Moore PT, Moore WR. Equilibration of cis- and trans-cycloalkenes Journal of the American Chemical Society. 82: 1744-1749. DOI: 10.1021/Ja01492A051  0.64
1959 Cope AC, Moore PT, Moore WR. RELATIVE STABILITIES OF cis- AND trans-CYCLONONENE, CYCLODECENE, CYCLOUNDECENE AND CYCLODODECENE Journal of the American Chemical Society. 81: 3153-3153. DOI: 10.1021/Ja01521A067  1
1959 Moore WR, Marcus E, Fenton SE, Arnold RT. Possible effect of hyperconjugation on solvolysis rates of benzhydryl chlorides and spectra of related compounds Tetrahedron. 5: 179-185.  0.36
1958 Cope AC, Moore PT, Moore WR. Cyclic polyolefins. XLIV. The structure of cycloöctatetraene oxide Journal of the American Chemical Society. 80: 5505-5507. DOI: 10.1021/Ja01553A048  0.64
1957 Cope AC. Amine oxides. III. Selective formation of olefins from unsymmetrical amine oxides and quaternary ammonium hydroxides Journal of the American Chemical Society. 79: 4720-4729. DOI: 10.1021/Ja01574A037  1
1955 Cope AC, Moore WR. Cyclic Polyolefins. Xxxviii. Position Isomers Of Disubstituted Cycloöctatetraenes Journal of the American Chemical Society. 77: 4939-4940. DOI: 10.1021/Ja01623A084  1
Show low-probability matches.